NKTR
Nektar Therapeutics
$0.53
Earnings Summary
Revenue | $24.14Mn |
Net Profits | $-45.84Mn |
Net Profit Margins | -189.85% |
Highlights
Nektar Therapeutics’s revenue jumped 2.2% since last year same period to $24.14Mn in the Q3 2023. On a quarterly growth basis, Nektar Therapeutics has generated 17.78% jump in its revenue since last 3-months.
Nektar Therapeutics’s net profit jumped 22.37% since last year same period to $-45.84Mn in the Q3 2023. On a quarterly growth basis, Nektar Therapeutics has generated 10.34% jump in its net profits since last 3-months.
Nektar Therapeutics’s net profit margin jumped 24.04% since last year same period to -189.85% in the Q3 2023. On a quarterly growth basis, Nektar Therapeutics has generated 23.87% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Nektar Therapeutics post its latest quarter earnings
EPS Estimate Current Quarter | -0.2 |
EPS Estimate Current Year | -0.2 |
Highlights
Nektar Therapeutics’s earning per share (EPS) estimates for the current quarter stand at -0.2 - a 0% jump from last quarter’s estimates.
Nektar Therapeutics’s earning per share (EPS) estimates for the current year stand at -0.2.
Key Ratios
Key ratios of the Nektar Therapeutics post its Q3 2023 earnings
Earning Per Share (EPS) | -0.24 |
Highlights
Nektar Therapeutics’s earning per share (EPS) jumped 22.58% since last year same period to -0.24 in the Q3 2023. This indicates that the Nektar Therapeutics has generated 22.58% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-10 | -0.25 | -0.32 | -28% |
2023-08-09 | -0.28 | -0.27 | 3.57% |
2023-11-08 | -0.2 | -0.24 | -20% |
₹0 US Stocks a/c Opening Fee